Neurological Surgery Doctors in Munster, IN Accepting Medicare

4 Neurological Surgery doctors found. Showing 1 - 4

Dr. Wayel Kaakaji, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 Macarthur Blvd, Ste 405, Munster, IN 46321 Phone: 219-836-5167    Fax: 219-836-5249

Dr. Ryan Khanna, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 901 Macarthur Blvd, Munster, IN 46321 Phone: 219-836-5167    Fax: 219-836-5249

Marc A Levin, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 801 Macarthur Blvd, Ste 405, Munster, IN 46321 Phone: 219-836-5167    Fax: 219-836-5249

Dr. Mohammad S Shukairy, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 Macarthur Blvd, Ste 405, Munster, IN 46321 Phone: 219-836-5167    Fax: 219-836-5249

News Archive

Study assesses protective capabilities of DNA vaccines against SIV

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that data generated from a pre-clinical collaborative study by National Cancer Institute (NCI) and Inovio scientists were published in the scientific journal Proceedings of the National Academy of Sciences in a paper entitled: "DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge."

First buprenorphine implant for opioid dependence treatment gets FDA approval

The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.

MSF official discusses WHO Working Group final report on R&D

The Results for Development Institute's Center for Global Health R&D Policy Assessment blog features an interview with Judit Rius Sanjuan, U.S. manager of the Access Campaign of Medecins Sans Frontieres (MSF), who discusses the final report of the WHO Consultative Expert Working Group on Research and Development: Financing and Coordination.

Ebola vaccine shows promise in clinical trials

"The results for tolerability, safety, and the immune response to the vaccine candidate are very promising," explains Prof Marylyn Addo. The antibodies which developed against the virus were still detectable after six months. Addo is convinced, "With this, a single vaccine could provide lasting protection against Ebola." The infectious disease specialist, who works for the German Center for Infection Research at the University Medical Center Hamburg Eppendorf in Hamburg, led the trial in Hamburg.

Researchers develop app to encourage and support cognitive creativity by dementia caregivers

Dementia is an ageing-related condition affecting mental acuity and memory. Incidence doubles in a population for every five years over the age of 65 years, so that almost one fifth of those living to 85 can expect to have the condition and a third of those over the age of 95 will likely be affected.

Read more Medical News

› Verified 2 days ago